Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings.

The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         National Heart, Lung, and Blood Institute Special Emphasis Panel; Bold New Bioengineering Methods and Approaches for Heart, Lung, Blood and Sleep Disorders and Diseases (R21).                    

*Date:*                         July 26-27, 2018.                    

*Time:*                         8:30 a.m. to 5:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         Embassy Suites at the Chevy Chase Pavilion 4300 Military Road NW, Washington, DC 20015.                    

*Contact Person:*                         Susan Wohler Sunnarborg, Ph.D., Scientific Review Officer, Office of Scientific Review/DERA, National, Heart, Lung, and Blood Institute, 6701 Rockledge Drive, Room 7182, Bethesda, MD 20892,                         *susan.sunnarborg@nih.gov*.                    

*Name of Committee:*                         National Heart, Lung, and Blood Institute Special Emphasis Panel; Clinical Trial Pilot Studies (R34).                    

*Date:*                         August 1-2, 2018.                    

*Time:*                         8:30 a.m. to 11:00 a.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         The William F. Bolger Center, 9600 Newbridge Drive, Potomac, MD 20854.                    

*Contact Person:*                         YingYing Li-Smerin, MD, Ph.D., Scientific Review Officer, Office of Scientific Review/DERA, National Heart, Lung, and Blood Institute, 6701 Rockledge Drive, Room 7184, Bethesda, MD 20892-7924, 301-827-7942,                         *lismerin@nhlbi.nih.gov*.                    

*Name of Committee:*                         National Heart, Lung, and Blood Institute Special Emphasis Panel; CLTR Conflict Meeting.                    

*Date:*                         August 2, 2018.                    

*Time:*                         11:00 a.m. to 3:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         The William F. Bolger Center, 9600 Newbridge Drive, Potomac, MD 20854.                     

*Contact Person:*                         YingYing Li-Smerin, MD, Ph.D., Scientific Review Officer, Office of Scientific Review/DERA, National Heart, Lung, and Blood Institute, 6701 Rockledge Drive, Room 7184, Bethesda, MD 20892-7924, 301-827-7942,                         *lismerin@nhlbi.nih.gov*.                    

*Name of Committee:*                         National Heart, Lung, and Blood Institute Special Emphasis Panel; Clinical Ancillary Studies (R01).                    

*Date:*                         August 10, 2018.                    

*Time:*                         8:30 a.m. to 5:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         The William F. Bolger Center, 9600 Newbridge Drive, Potomac, MD 20854.                    

*Contact Person:*                         YingYing Li-Smerin, MD, Ph.D., Scientific Review Officer, Office of Scientific Review/DERA, National Heart, Lung, and Blood Institute, 6701 Rockledge Drive, Room 7184, Bethesda, MD 20892-7924, 301-827-7942,                         *lismerin@nhlbi.nih.gov*.                    

(Catalogue of Federal Domestic Assistance Program Nos. 93.233, National Center for Sleep Disorders Research; 93.837, Heart and Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, Blood Diseases and Resources Research, National Institutes of Health, HHS)

Dated: June 29, 2018.

Michelle D. Trout,

Program Analyst, Office of Federal Advisory Committee Policy.

[FR Doc. 2018-14453 Filed 7-5-18; 8:45 am]

 BILLING CODE 4140-01-P